Ehud Gelblum

Ehud Gelblum serves as a fractional Chief Financial Officer for multiple innovative companies, including Novadiscovery, Cardiosense, and Parsley Health, focusing on advancements in healthcare technology and digital health solutions. Gelblum also holds a senior financial advisory role at Wavely Diagnostics and has been an active member and investor in angel investment groups such as New York Angels and Mid Atlantic Bio Angels since 2018. Previously, Gelblum was the Chief Financial Officer at caresyntax and had interim leadership at UNTUCKit. Educational credentials include a Ph.D. and MSE in Electrical Engineering from Columbia University, alongside a BSE in Finance and Accounting from The Wharton School, and an undergraduate degree in Electrical Engineering from the University of Pennsylvania.